Financhill
Sell
45

JKS Quote, Financials, Valuation and Earnings

Last price:
$23.77
Seasonality move :
4.61%
Day range:
$23.12 - $24.30
52-week range:
$16.70 - $38.37
Dividend yield:
12.61%
P/E ratio:
40.09x
P/S ratio:
0.09x
P/B ratio:
0.41x
Volume:
2M
Avg. volume:
1.2M
1-year change:
-26.48%
Market cap:
$1.2B
Revenue:
$16.8B
EPS (TTM):
$0.59
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $4.3B $5.1B $6.3B $12.4B $16.8B
Revenue Growth (YoY) 13.68% 18.2% 24.22% 95.72% 35.57%
 
Cost of Revenues $3.5B $4.2B $5.3B $10.5B $14.1B
Gross Profit $786.4M $894.3M $1B $1.8B $2.7B
Gross Profit Margin 18.26% 17.57% 16.31% 14.77% 16.05%
 
R&D Expenses $47M $56.4M $71.5M $107.9M $128.9M
Selling, General & Admin $479.1M $562.7M $746.5M $1.6B $1.6B
Other Inc / (Exp) -$28.9M -$154.4M -$19.8M $85.6M $28.2M
Operating Expenses $517M $591.3M $745.9M $1.5B $1.6B
Operating Income $269.4M $303M $285.3M $281.7M $1.1B
 
Net Interest Expenses $59.4M $66.5M $96.6M $73.1M $87.3M
EBT. Incl. Unusual Items $181.1M $82.1M $168.8M $294.3M $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $40.2M $25.9M $30.1M $90.1M $178.2M
Net Income to Company $133.8M $48.6M $148M $233M $912.2M
 
Minority Interest in Earnings -$3.7M -$15.2M -$36.3M -$140.6M -$424.8M
Net Income to Common Excl Extra Items $130.1M $33.4M $111.7M $92.4M $487.4M
 
Basic EPS (Cont. Ops) $3.07 $0.75 $2.34 $1.86 $9.39
Diluted EPS (Cont. Ops) $2.81 $0.75 $1.25 $1.85 $8.61
Weighted Average Basic Share $42.3M $44.7M $47.7M $49.5M $51.9M
Weighted Average Diluted Share $42.3M $44.7M $51.4M $50.1M $56.5M
 
EBITDA $404.2M $380.4M $577.7M $865.8M $2.4B
EBIT $262.5M $180M $298.6M $455M $1.2B
 
Revenue (Reported) $4.3B $5.1B $6.3B $12.4B $16.8B
Operating Income (Reported) $269.4M $303M $285.3M $281.7M $1.1B
Operating Income (Adjusted) $262.5M $180M $298.6M $455M $1.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.3B $1.3B $2.8B $4.4B $3.4B
Revenue Growth (YoY) 18.78% 4.47% 115.33% 54.39% -22.19%
 
Cost of Revenues $1.1B $1.1B $2.4B $3.6B $2.9B
Gross Profit $215.9M $200.1M $448.4M $847.5M $538.5M
Gross Profit Margin 17.05% 15.12% 15.74% 19.27% 15.73%
 
R&D Expenses $15.2M $19.3M $29.4M $30.1M $29.1M
Selling, General & Admin $121.8M $163.6M $409.4M $400.3M $467.6M
Other Inc / (Exp) -$54.6M $30.1M $109.4M -$25.4M -$51.8M
Operating Expenses $128M $173.1M $405.9M $421.6M $436.4M
Operating Income $87.9M $27M $42.5M $426M $102.1M
 
Net Interest Expenses $18.7M $25.6M $18.8M $20.5M $28.2M
EBT. Incl. Unusual Items $14.6M $31.5M $132.8M $380.1M $22M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $10M $3.4M $22M $55.7M $20.7M
Net Income to Company $100.8M -- -- -- --
 
Minority Interest in Earnings -$7.2M -$125.5K -$36.2M -$138.4M $2.3M
Net Income to Common Excl Extra Items $989.8K $30M $80.3M $182.9M $3.1M
 
Basic EPS (Cont. Ops) $0.02 $0.63 $1.60 $3.55 $0.06
Diluted EPS (Cont. Ops) $0.02 $0.07 $0.93 $2.55 $0.06
Weighted Average Basic Share $44.5M $47.7M $50.1M $51.6M $51.2M
Weighted Average Diluted Share $44.5M $51.3M $54.8M $55.8M $51.2M
 
EBITDA $33.3M $57M $151.6M $415.5M $64M
EBIT $33.3M $57M $151.6M $415.5M $64M
 
Revenue (Reported) $1.3B $1.3B $2.8B $4.4B $3.4B
Operating Income (Reported) $87.9M $27M $42.5M $426M $102.1M
Operating Income (Adjusted) $33.3M $57M $151.6M $415.5M $64M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5B $5.2B $10.6B $16.4B $14.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.1B $4.3B $9B $13.7B $12.7B
Gross Profit $912.1M $847.1M $1.6B $2.7B $1.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $49.1M $74.3M $92.8M $122M $131.5M
Selling, General & Admin $523.8M $630.5M $1.4B $1.6B $1.7B
Other Inc / (Exp) -$70.8M -$84.4M $11.5M $107.4M $109.2M
Operating Expenses $559M $633.2M $1.4B $1.6B $1.6B
Operating Income $353.1M $213.9M $263.7M $1.1B $278M
 
Net Interest Expenses $61.1M $91.4M $80.2M $74M $97.5M
EBT. Incl. Unusual Items $221.2M $38M $194.7M $1.1B $289.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $60.3M $6.9M $70.9M $187.7M $118.7M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$16.3M -$25.4M -$103.1M -$433M -$84.8M
Net Income to Common Excl Extra Items $138.8M $17.5M $27.9M $577.9M $78.4M
 
Basic EPS (Cont. Ops) $3.12 $0.31 $0.58 $11.47 $1.45
Diluted EPS (Cont. Ops) $2.28 -$2.44 -$0.23 $8.72 $0.59
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $332.8M $188.6M $308.4M $1.4B $441.2M
EBIT $282.3M $129.5M $308.4M $1.4B $441.2M
 
Revenue (Reported) $5B $5.2B $10.6B $16.4B $14.5B
Operating Income (Reported) $353.1M $213.9M $263.7M $1.1B $278M
Operating Income (Adjusted) $282.3M $129.5M $308.4M $1.4B $441.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3.7B $3.8B $8B $12.2B $10B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3B $3.2B $6.8B $10.1B $8.7B
Gross Profit $666.6M $619.8M $1.2B $2.1B $1.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $36M $53.6M $74.9M $89.9M $92.7M
Selling, General & Admin $385.4M $451.9M $1.1B $1.1B $1.3B
Other Inc / (Exp) -$69.2M $4M $35.6M $63.9M $142.5M
Operating Expenses $409.7M $450.5M $1.1B $1.1B $1.1B
Operating Income $256.9M $169.3M $147.2M $981.7M $143.7M
 
Net Interest Expenses $49.2M $74.1M $57.6M $58.3M $69M
EBT. Incl. Unusual Items $138.5M $99.2M $124.8M $987.2M $217.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $28.9M $10.4M $51M $150.4M $90.8M
Net Income to Company $100.8M -- -- -- --
 
Minority Interest in Earnings -$13M -$23.2M -$89.9M -$384.5M -$44.1M
Net Income to Common Excl Extra Items $86.3M $74.3M -$9.5M $484.5M $74.3M
 
Basic EPS (Cont. Ops) $1.94 $1.56 -$0.21 $9.48 $1.37
Diluted EPS (Cont. Ops) $1.33 -$0.26 -$0.88 $7.90 $0.52
Weighted Average Basic Share $133.6M $143M $147.7M $153.2M $157.2M
Weighted Average Diluted Share $138.4M $150.4M $152.4M $164.4M $159.6M
 
EBITDA $187.7M $173.3M $182.4M $1.1B $328.3M
EBIT $187.7M $173.3M $182.4M $1.1B $328.3M
 
Revenue (Reported) $3.7B $3.8B $8B $12.2B $10B
Operating Income (Reported) $256.9M $169.3M $147.2M $981.7M $143.7M
Operating Income (Adjusted) $187.7M $173.3M $182.4M $1.1B $328.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $808.1M $1.1B $1.3B $1.5B $2.3B
Short Term Investments -- $87.2M $23.5M $15.1M $144.4M
Accounts Receivable, Net $827.1M $756.9M $1.2B $2.4B $3.2B
Inventory $831.6M $1.3B $2.1B $2.5B $2.6B
Prepaid Expenses $440.3M $276.4M $300.8M $482.4M $644.1M
Other Current Assets $14.9M $22M $20.7M $477M $480M
Total Current Assets $4.5B $5.2B $7.1B $9.9B $11.7B
 
Property Plant And Equipment $1.9B $2.3B $3.6B $5B $6.3B
Long-Term Investments $39.7M $29.7M $99.4M $248M $313.4M
Goodwill -- -- -- -- --
Other Intangibles $90.7M $122M $179.7M $219M $337.2M
Other Long-Term Assets $89.7M $229.1M $189.5M $207.4M $224.5M
Total Assets $6.8B $8.1B $11.5B $15.7B $19.2B
 
Accounts Payable $713M $681.2M $1.1B $1.5B $2.2B
Accrued Expenses $208.5M $227.5M $292.6M $426.4M $522M
Current Portion Of Long-Term Debt $1.3B $1.5B $2.1B $1.8B $2B
Current Portion Of Capital Lease Obligations $38.3M $49.1M $40.4M $33.9M $22M
Other Current Liabilities $144.6M -- $87.2M -- $157.6M
Total Current Liabilities $4.5B $4.8B $7.1B $9.4B $11.4B
 
Long-Term Debt $330.8M $1.1B $1.7B $2B $2.3B
Capital Leases -- -- -- -- --
Total Liabilities $5.1B $6.2B $9.2B $11.8B $14.4B
 
Common Stock $3.5K $4K $4.1K $4.1K $4.1K
Other Common Equity Adj $107.6M $86.2M -$24.2M $31.5M $50.7M
Common Equity $1.3B $1.5B $1.7B $2.4B $2.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $448.4M $459.6M $507.9M $1.5B $1.9B
Total Equity $1.8B $2B $2.2B $3.9B $4.7B
 
Total Liabilities and Equity $6.8B $8.1B $11.5B $15.7B $19.2B
Cash and Short Terms $808.1M $1.2B $1.3B $1.5B $2.4B
Total Debt $2.7B $4.1B $5.7B $6.8B $7.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $845.9M $1B $2B $1.9B $3.2B
Short Term Investments -- $64.9M $14.6M $7.1M --
Accounts Receivable, Net $819M $660M $1.6B $3.6B $2.8B
Inventory $1.1B $2.1B $3B $2.6B $2.2B
Prepaid Expenses $402M $360.1M $936.7M $545.8M $429.8M
Other Current Assets $18.2M $434.3M $400.9M $488.3M $781.1M
Total Current Assets $4.7B $6.1B $10.2B $11.1B $10.6B
 
Property Plant And Equipment $2.1B $3B $4.4B $5B $6.6B
Long-Term Investments $25.4M $54.9M $121M $322.5M $263.7M
Goodwill -- -- -- -- --
Other Intangibles $110.5M $135.6M $255M $246.7M $309.2M
Other Long-Term Assets $156.3M $539.9M $547.2M $584.9M $498M
Total Assets $7.3B $9.9B $15.6B $17.5B $18.6B
 
Accounts Payable $716.1M $773.3M $1.1B $1.9B $1.6B
Accrued Expenses $125.2M $167.9M $231.5M $326.5M $371.6M
Current Portion Of Long-Term Debt $1.7B $1.9B $1.8B $1.8B $1.3B
Current Portion Of Capital Lease Obligations $36.2M $39.8M $38.1M $20.6M $17.2M
Other Current Liabilities -- -- -- $208.2M --
Total Current Liabilities $4.6B $5.7B $9.4B $10B $8.7B
 
Long-Term Debt $718.7M $1.7B $2.3B $2.4B $3.9B
Capital Leases -- -- -- -- --
Total Liabilities $5.5B $7.7B $12B $12.9B $13.6B
 
Common Stock $3.7K $4K $3.9K $4K --
Other Common Equity Adj $99.2M $102.2M $122.7M $53.6M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $357.1M $487.2M $1.4B $1.8B $2.1B
Total Equity $1.8B $2.2B $3.6B $4.5B $5B
 
Total Liabilities and Equity $7.3B $9.9B $15.6B $17.5B $18.6B
Cash and Short Terms $845.9M $1.1B $2B $1.9B $3.2B
Total Debt $3.6B $5B $8B $7.3B $7B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $133.8M $48.6M $148M $233M $912.2M
Depreciation & Amoritzation $141.7M $200.4M $279.1M $410.8M $1.2B
Stock-Based Compensation $662.8K $133.8K $1.5M $149M $122M
Change in Accounts Receivable -$29.1M $137.1M -$604.1M -$2.1B -$593M
Change in Inventories -$30.4M -$409M -$882.6M -$901.2M -$542.2M
Cash From Operations $204.2M $85.7M $66.7M -$863.6M $2B
 
Capital Expenditures $538.1M $600.8M $1.3B $1.8B $2.2B
Cash Acquisitions -$14M $4.2M -$48.8M -$105.2M $5.1M
Cash From Investing -$872.3M -$712.7M -$1.8B -$1.8B -$2.1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$79.1M
Special Dividend Paid
Long-Term Debt Issued $2.9B $4.1B $5.5B $5.7B $4.3B
Long-Term Debt Repaid -$2.3B -$3.7B -$3.8B -$4.1B -$3B
Repurchase of Common Stock -- -$4.2M -- -- -$11.2M
Other Financing Activities $373.1M $533M -- $1.4B $19.9M
Cash From Financing $1.1B $912.5M $1.9B $3B $1.2B
 
Beginning Cash (CF) $504.1M $909.1M $1.3B $1.4B $1.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $400.6M $285.5M $176.4M $289.7M $1B
Ending Cash (CF) $908.3M $1.2B $1.4B $1.7B $2.7B
 
Levered Free Cash Flow -$333.9M -$515.1M -$1.3B -$2.7B -$286.2M
Period Ending 2016-09-30 2017-09-30 2018-09-30 2019-09-30 2020-09-30
Net Income to Stockholders $148.3M $17.8M -- $75.8M $100.8M
Depreciation & Amoritzation $96.2M $64.6M -- $88.8M $143.2M
Stock-Based Compensation $8.3M $6.9M -- $1.6M $125.1K
Change in Accounts Receivable -$284.7M -$14.8M -- $12.9M -$87.6M
Change in Inventories -$48.5M -$152.7M -- -$63.2M -$297.7M
Cash From Operations -$51.8M -$134.6M -- $17.6M -$243.3M
 
Capital Expenditures $583.1M $282.4M -- $442.3M $348.1M
Cash Acquisitions $10.5M $214.4K -- -$23.8M $6M
Cash From Investing -$711.1M -$383M -- -$726M -$312.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.9B $2.5B -- $2.3B $2.4B
Long-Term Debt Repaid -$1.2B -$2.1B -- -$1.7B -$2B
Repurchase of Common Stock -- -- -- -- -$4.2M
Other Financing Activities $19.4M -$4.7M -- $231.9M $123.8M
Cash From Financing $709.6M $467.4M -- $806.9M $579.5M
 
Beginning Cash (CF) $552.5M $375.2M -- $496.3M $906.1M
Foreign Exchange Rate Adjustment $4M -$7.3M -- $3.7M -$4.9M
Additions / Reductions -$53.3M -$50.2M -- $98.5M $23.8M
Ending Cash (CF) $503.2M $317.7M -- $598.4M $925M
 
Levered Free Cash Flow -$634.9M -$417M -- -$424.7M -$591.4M
Period Ending 2017-06-30 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $12.9M $6.9M -- $1.6M $125.1K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures $746.3M $282.4M -- $442.3M $348.1M
Cash Acquisitions $12.8M $214.4K -- -$23.8M $6M
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$1.2B -- -- -- --
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock